In vivo electroporation enhances vaccine-mediated therapeuticcontrol of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells (2017)
- Authors:
- Autor USP: FERREIRA, LUIS CARLOS DE SOUZA - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2017.11.011
- Subjects: MICROBIOLOGIA; PAPILLOMAVIRUS; CÉLULAS CULTIVADAS DE TUMOR; DNA VIRAL; ADJUVANTES IMUNOLÓGICOS; ELETROPORAÇÃO
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SALES, Natiely Silva et al. In vivo electroporation enhances vaccine-mediated therapeuticcontrol of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells. Vaccine, v. 35, n. 52, p. 7240-7249, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.11.011. Acesso em: 27 fev. 2026. -
APA
Sales, N. S., Silva, J. R. da, Aps, L. R. de M. M., Silva, M. de O., Ribeiro, B. F. M. M. P., Ferreira, L. C. de S., & Diniz, M. de O. (2017). In vivo electroporation enhances vaccine-mediated therapeuticcontrol of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells. Vaccine, 35( 52), 7240-7249. doi:10.1016/j.vaccine.2017.11.011 -
NLM
Sales NS, Silva JR da, Aps LR de MM, Silva M de O, Ribeiro BFMMP, Ferreira LC de S, Diniz M de O. In vivo electroporation enhances vaccine-mediated therapeuticcontrol of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells [Internet]. Vaccine. 2017 ; 35( 52): 7240-7249.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.011 -
Vancouver
Sales NS, Silva JR da, Aps LR de MM, Silva M de O, Ribeiro BFMMP, Ferreira LC de S, Diniz M de O. In vivo electroporation enhances vaccine-mediated therapeuticcontrol of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells [Internet]. Vaccine. 2017 ; 35( 52): 7240-7249.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.011 - Evaluation of experimental conditions for quantification of LT produced by human derived enterotoxigenic Escherichia coli strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains based on intimin expression by recombinant Bacillus subtilis strains
- New vaccine approaches against enteropathogenic and enteroheamorrhagic Escherichia coli strains
- Gene delivery and immunomodulatory effects of plasmid DNA associated with Branched Amphiphilic Peptide Capsules
- Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action
- Protection against HPV-16-associated tumors requires the activation of CD8+ effector memory T cells and the control of myeloid-derived suppressor cells
- Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors
- Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
- Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
- Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD
Informações sobre o DOI: 10.1016/j.vaccine.2017.11.011 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
